2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Classical hematology
1
Conditions
Venous Thrombosis
1
Venous Thromboembolism
1
Thromboembolism of Vein VTE in Colorectal Cancer
1
Thromboembolism
1
Pulmonary Embolism
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Kidney Neoplasms
1
Fatigue
1
Carcinoma, Renal Cell
1
Carcinoma, Ovarian Epithelial
1
Interventions
apixaban
22
Rivaroxaban
16
Dalteparin
16
Enoxaparin
11
Heparin, Low-Molecular-Weight
10
Tinzaparin
8
Aspirin
8
Fondaparinux
4
Dabigatran
4
edoxaban
3
Warfarin
3
Nadroparin
3
bemiparin
2
abelacimab
2
Rosuvastatin Calcium
2
Observation
2
MAA868
2
sotorasib
1
ribociclib
1
reviparin
1
palbociclib
1
isoquercitrin
1
enoxaparin sodium
1
certoparin
1
calcium heparin
1
betrixaban
1
argatroban
1
acarboxyprothrombin
1
abemaciclib
1
Tacrolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Venous Thromboembolism
×
isoquercitrin
×
Clear all
NCT06861088
2026-02-02
CATIQ P3
Quercis Pharma AG
Phase 3
Recruiting
480 enrolled